Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tedford

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Immunology|August 8, 1998
Vav links antigen-receptor signaling to the actin cytoskeletonK D Fischer, K Tedford, J M Penninger
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 16, 2005
From rhetoric to reality: including patient voices in supportive cancer care planningSara K Tedford Gold, Julia Abelson, Cathy A Charles
Current Biology : CB|April 1, 1997
Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substratesK Tedford, S Kim, D Sa, et al.
Canadian Journal of Sport Sciences = Journal Canadien Des Sciences Du Sport|December 1, 1990
Concentric and eccentric quadriceps torque in pre-adolescent malesN G Mohtadi, G N Kiefer, K Tedford, et al.
Nature Immunology|August 30, 2001
Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responsesI Girkontaite, K Missy, V Sakk, et al.
Nature Immunology|May 29, 2001
Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signalingK Tedford, L Nitschke, I Girkontaite, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigensM F Bachmann, L Nitschke, C Krawczyk, et al.
European Journal of Immunology|June 8, 1999
The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulationJ M Penninger, K D Fischer, T Sasaki, et al.
Current Biology : CB|May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptorK D Fischer, Y Y Kong, H Nishina, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Immunology|August 8, 1998
Vav links antigen-receptor signaling to the actin cytoskeletonK D Fischer, K Tedford, J M Penninger
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 16, 2005
From rhetoric to reality: including patient voices in supportive cancer care planningSara K Tedford Gold, Julia Abelson, Cathy A Charles
Current Biology : CB|April 1, 1997
Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substratesK Tedford, S Kim, D Sa, et al.
Canadian Journal of Sport Sciences = Journal Canadien Des Sciences Du Sport|December 1, 1990
Concentric and eccentric quadriceps torque in pre-adolescent malesN G Mohtadi, G N Kiefer, K Tedford, et al.
Nature Immunology|August 30, 2001
Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responsesI Girkontaite, K Missy, V Sakk, et al.
Nature Immunology|May 29, 2001
Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signalingK Tedford, L Nitschke, I Girkontaite, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigensM F Bachmann, L Nitschke, C Krawczyk, et al.
European Journal of Immunology|June 8, 1999
The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulationJ M Penninger, K D Fischer, T Sasaki, et al.
Current Biology : CB|May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptorK D Fischer, Y Y Kong, H Nishina, et al.
Pageof 1